Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Amicus Therapeutics (FOLD)

Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
2 ‘Strong-Buy’-Rated Stocks With Around 50% Upside

Wall Street predicts that these rapidly expanding growth stocks will generate outsized gains this year.

$SPX : 5,254.35 (+0.11%)
$NASX : 16,379.46 (-0.12%)
CVE : 19.99 (+0.76%)
FOLD : 11.78 (-0.67%)
NGG24 : 2.490s (-8.19%)
Amicus Therapeutics: Q3 Earnings Snapshot

Amicus Therapeutics: Q3 Earnings Snapshot

FOLD : 11.78 (-0.67%)
WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe Disease

/PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), congratulates...

FOLD : 11.78 (-0.67%)
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023

Stocks that traded heavily or had substantial price changes on Friday: Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall

OPK : 1.2000 (+12.15%)
MTN : 222.83 (+1.20%)
FOLD : 11.78 (-0.67%)
BLK : 833.70 (-0.17%)
NKE : 93.98 (-0.16%)
WuXi Biologics Reports Solid 2023 Interim Results

Revenue Increased by 17.8% Y-o-Y to RMB8,492.0 Million Adjusted Net Profit Rose by 0.4% to RMB2,925.6 Million Non-COVID Revenue Achieved 59.7% Y-o-Y Growth,...

FOLD : 11.78 (-0.67%)
Amicus Therapeutics: Q2 Earnings Snapshot

Amicus Therapeutics: Q2 Earnings Snapshot

FOLD : 11.78 (-0.67%)
Company News for May 11, 2023

Companies in The news Are: VSH,COHRICL,FOLD

FOLD : 11.78 (-0.67%)
VSH : 22.68 (-0.87%)
COHR : 60.62 (-0.43%)
ICL : 5.38 (+0.37%)
Amicus (FOLD) Q1 Earnings Miss, Galafold Sales Grow

Amicus (FOLD) incurs wider-than-expected loss in the first quarter. Revenues, however, beat estimates. The company reiterates its 2023 guidance.

FOLD : 11.78 (-0.67%)
RCUS : 18.88 (+3.68%)
ALLO : 4.47 (+0.22%)
OCUP : 2.01 (-0.50%)
Amicus Therapeutics (FOLD) Reports Q1 Loss, Tops Revenue Estimates

Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of -38.46% and 5.03%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

FOLD : 11.78 (-0.67%)
TLIS : 8.75 (-1.41%)
Amicus Therapeutics: Q1 Earnings Snapshot

Amicus Therapeutics: Q1 Earnings Snapshot

FOLD : 11.78 (-0.67%)

Barchart Exclusives

Ford Motor vs. Toyota: Which Hybrid EV Stock Is a Better Buy?
With hybrid EVs gaining popularity, let’s find out whether shares of Ford or Toyota are a better buy. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar